Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration

Authors

Jeffrey R. Willis (ORCID: https://orcid.org/0000-0002-6712-1144)
Shriji Patel
Jennifer I. Lim (ORCID: https://orcid.org/0000-0001-7791-6998)
Giuseppe Querques
Robyn H. Guymer (ORCID: https://orcid.org/0000-0002-9441-4356)
Chui Ming Gemmy Cheung (ORCID: https://orcid.org/0000-0003-3358-3516)
Siegfried Priglinger (ORCID: https://orcid.org/0000-0002-5580-612X)
Philippe Margaron (ORCID: https://orcid.org/0000-0001-5215-3373)
Ming Yang
Audrey Souverain

Institutions

Roche (Switzerland) (CH)
Vita-Salute San Raffaele University (IT)
Singapore National Eye Center (SG)
LMU Klinikum (DE)
University of Illinois Chicago (US)
Centre for Eye Research Australia (AU)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Ludwig-Maximilians-Universität München (DE)

Publication Details

Journal: Ophthalmology
Published: 2024-11-29
DOI: https://doi.org/10.1016/j.ophtha.2024.11.023
Citations: 12
Primary Topic: Atherosclerosis and Cardiovascular Diseases
Type: article
Field-Weighted Citation Impact: 2.89

Funders

F. Hoffmann-La Roche

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration

Jeffrey R. Willis, Shriji Patel, Jennifer I. Lim, Giuseppe Querques et al.

Nov 29, 2024

12 citations

Ophthalmology

Atherosclerosis and Cardiovascular Diseases

2.89

article

Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration

Jeffrey R. Willis, Shriji Patel, Jennifer I. Lim, Giuseppe Querques, Robyn H. Guymer, Chui Ming Gemmy Cheung, Siegfried Priglinger, Philippe Margaron, Ming Yang, Audrey Souverain

November 29, 2024article en

12 citations

Abstract

No abstract available for this paper.

OphthalmologyVol. 132(5)

Roche (Switzerland) (CH), Vita-Salute San Raffaele University (IT), Singapore National Eye Center (SG), LMU Klinikum (DE), University of Illinois Chicago (US), Centre for Eye Research Australia (AU), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Ludwig-Maximilians-Universität München (DE)

F. Hoffmann-La Roche

Zero hunger

Openalex Percentile: Top 9%

Atherosclerosis and Cardiovascular Diseases

2.89

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration — Jeffrey R. Willis, Shriji Patel, et al. · Ophthalmology (2024) | TGRS Research Map | TGRS